Endotoxin temporarily impairs canine jejunal absorption of water, electrolytes, and glucose

J. Cullen,Lynda L. Hemann,K. Ephgrave,Marilyn M. Hinkhous

DOI: https://doi.org/10.1016/S1091-255X(97)80122-9

1997-05-01

Journal of Gastrointestinal Surgery

Abstract:

What problem does this paper attempt to address?

Exploring the potential of vagus nerve stimulation in treating brain diseases: a review of immunologic benefits and neuroprotective efficacy

Zeping Jin,Jing Dong,Yang Wang,Yunpeng Liu

DOI: https://doi.org/10.1186/s40001-023-01439-2

IF: 4.981

2023-10-19

European Journal of Medical Research

Abstract:The vagus nerve serves as a critical connection between the central nervous system and internal organs. Originally known for its effectiveness in treating refractory epilepsy, vagus nerve stimulation (VNS) has shown potential for managing other brain diseases, including ischaemic stroke, traumatic brain injury, Parkinson's disease, and Alzheimer's disease. However, the precise mechanisms of VNS and its benefits for brain diseases are not yet fully understood. Recent studies have found that VNS can inhibit inflammation, promote neuroprotection, help maintain the integrity of the blood-brain barrier, have multisystemic modulatory effects, and even transmit signals from the gut flora to the brain. In this article, we will review several essential studies that summarize the current theories of VNS and its immunomodulatory effects, as well as the therapeutic value of VNS for brain disorders. By doing so, we aim to provide a better understanding of how the neuroimmune network operates and inspire future research in this field.

medicine, research & experimental
Crystal structure of methionine aminopeptidase from hyperthermophile, Pyrococcus furiosus.

T. Tahirov,H. Oki,T. Tsukihara,K. Ogasahara,K. Yutani,K. Ogata,Yukiko Izu,S. Tsunasawa,I. Kato

DOI: https://doi.org/10.1006/JMBI.1998.2146

IF: 6.151

1998-11-20

Journal of Molecular Biology

Abstract:The structure of methionine aminopeptidase from hyperthermophile Pyrococcus furiosus (PfMAP) with an optimal growth temperature of 100 degreesC was determined by the multiple isomorphous replacement method and refined in three different crystal forms, one monoclinic and two hexagonal, at resolutions of 2.8, 2.9, and 3.5 A. The resolution of the monoclinic crystal form was extended to 1.75 A by water-mediated transformation to a low-humidity form, and the obtained diffraction data used for high-resolution structure refinement. This is the first description of a eukaryotic type methionine aminopeptidase structure. The PfMAP molecule is composed of two domains, a catalytic domain and an insertion domain, connected via two antiparallel beta-strands. The catalytic domain, which possesses an internal 2-fold symmetry and contains two cobalt ions in the active site, resembles the structure of a prokaryotic type MAP from Escherichia coli (EcMAP), while the structure of the insertion domain containing three helices has a novel fold and accounts for a major difference between the eukaryotic and prokaryotic types of methionine aminopeptidase. Analysis of the PfMAP structure in comparison with EcMAP and other mesophile proteins reveals several factors which may contribute to the hyperthermostability of PfMAP: (1) a significantly high number of hydrogen bonds and ion-pairs between side-chains of oppositely charged residues involved in the stabilization of helices; (2) an increased number of hydrogen bonds between the positively charged side-chain and neutral oxygen; (3) a larger number of buried water molecules involved in crosslinking the backbone atoms of sequentially separate segments; (4) stabilization of two antiparallel beta-strands connecting the two domains of the molecule by proline residues; (5) shortening of N and C-terminal tails and stabilization of the loop c3E by deletion of three residues.
Neuroimmunomodulation of vagus nerve stimulation and the therapeutic implications

Yi-Ting Fang,Ye-Ting Lin,Wu-Lung Tseng,Philip Tseng,Gia-Linh Hua,Ying-Jui Chao,Yi-Jen Wu

DOI: https://doi.org/10.3389/fnagi.2023.1173987

IF: 4.8

2023-07-07

Frontiers in Aging Neuroscience

Abstract:Vagus nerve stimulation (VNS) is a technology that provides electrical stimulation to the cervical vagus nerve and can be applied in the treatment of a wide variety of neuropsychiatric and systemic diseases. VNS exerts its effect by stimulating vagal afferent and efferent fibers, which project upward to the brainstem nuclei and the relayed circuits and downward to the internal organs to influence the autonomic, neuroendocrine, and neuroimmunology systems. The neuroimmunomodulation effect of VNS is mediated through the cholinergic anti-inflammatory pathway that regulates immune cells and decreases pro-inflammatory cytokines. Traditional and non-invasive VNS have Food and Drug Administration (FDA)-approved indications for patients with drug-refractory epilepsy, treatment-refractory major depressive disorders, and headaches. The number of clinical trials and translational studies that explore the therapeutic potentials and mechanisms of VNS is increasing. In this review, we first introduced the anatomical and physiological bases of the vagus nerve and the immunomodulating functions of VNS. We covered studies that investigated the mechanisms of VNS and its therapeutic implications for a spectrum of brain disorders and systemic diseases in the context of neuroimmunomodulation.

neurosciences,geriatrics & gerontology,gerontology
Advances in VNS efficiency and mechanisms of action on cognitive functions

Wendi Wang,Rui Li,Chuangtao Li,Qimin Liang,Xiaolin Gao

DOI: https://doi.org/10.3389/fphys.2024.1452490

IF: 4

2024-10-10

Frontiers in Physiology

Abstract:Objective: This systematic review aims to comprehensively analyze the efficacy and underlying mechanisms of vagus nerve stimulation (VNS) in enhancing cognitive functions and its therapeutic potential for various cognitive impairments. The review focuses on the impact of VNS on emotional processing, executive functions, learning, memory, and its clinical applications in conditions such as epilepsy, depression, Alzheimer's disease, and other neurological disorders. Methods: A systematic search of electronic databases (PubMed, Scopus, Web of Science) was conducted using the keywords "vagus nerve stimulation," "cognitive enhancement," "emotional processing," "executive function," "learning and memory," "epilepsy," "depression," "Alzheimer's disease," "neurological disorders," "attention-deficit/hyperactivity disorder," "sleep disorders," and "long COVID." The inclusion criteria encompassed controlled trials, longitudinal studies, and meta-analyses published in English between 2000 and July 2024. Results: A comprehensive review of 100 articles highlighted the cognitive effects of Vagus Nerve Stimulation (VNS). Studies show that VNS, especially through transcutaneous auricular VNS (taVNS), enhances emotional recognition, particularly for facial expressions, and improves selective attention under high cognitive demands. Additionally, VNS enhances learning and memory, including associative memory and spatial working memory tasks. In clinical applications, VNS exhibits promising benefits for improving cognitive functions in treatment-resistant epilepsy, depression, and Alzheimer's disease. Conclusion: VNS represents a promising therapeutic approach for enhancing cognitive function across diverse patient populations. The reviewed evidence highlights its efficacy in modulating cognitive domains in healthy individuals and improving cognition in neurological conditions. However, the comparative effectiveness of different VNS modalities and the differential effects of online versus offline VNS on cognitive psychology require further investigation. Future research should focus on optimizing VNS protocols and elucidating specific cognitive domains that benefit most from VNS interventions. This ongoing exploration is essential for maximizing the therapeutic potential of VNS in clinical practice.

physiology
Research advances in the application of vagus nerve electrical stimulation in ischemic stroke

Keling Cheng,Zhiyong Wang,Junhui Bai,Jie Xiong,Jianmin Chen,Jun Ni

DOI: https://doi.org/10.3389/fnins.2022.1043446

IF: 4.3

2022-10-29

Frontiers in Neuroscience

Abstract:Stroke seriously endangers human well-being and brings a severe burden to family and society. Different post-stroke dysfunctions result in an impaired ability to perform activities of daily living. Standard rehabilitative therapies may not meet the requirements for functional improvement after a stroke; thus, alternative approaches need to be proposed. Currently, vagus nerve stimulation (VNS) is clinically applied for the treatment of epilepsy, depression, cluster headache and migraine, while its treatment of various dysfunctions after an ischemic stroke is still in the clinical research stage. Recent studies have confirmed that VNS has neuroprotective effects in animal models of transient and permanent focal cerebral ischemia, and that its combination with rehabilitative training significantly improves upper limb motor dysfunction and dysphagia. In addition, vagus-related anatomical structures and neurotransmitters are closely implicated in memory–cognition enhancement processes, suggesting that VNS is promising as a potential treatment for cognitive dysfunction after an ischemic stroke. In this review, we outline the current status of the application of VNS (invasive and non-invasive) in diverse functional impairments after an ischemic stroke, followed by an in-depth discussion of the underlying mechanisms of its mediated neuroprotective effects. Finally, we summarize the current clinical implementation challenges and adverse events of VNS and put forward some suggestions for its future research direction. Research on VNS for ischemic stroke has reached a critical stage. Determining how to achieve the clinical transformation of this technology safely and effectively is important, and more animal and clinical studies are needed to clarify its therapeutic mechanism.

neurosciences
Vagus nerve stimulation (VNS): recent advances and future directions

Christopher W. Austelle,Stewart S. Cox,Kristin E. Wills,Bashar W. Badran

DOI: https://doi.org/10.1007/s10286-024-01065-w

2024-10-05

Clinical Autonomic Research

Abstract:Purpose Vagus nerve stimulation (VNS) is emerging as a unique and potent intervention, particularly within neurology and psychiatry. The clinical value of VNS continues to grow, while the development of noninvasive options promises to change a landscape that is already quickly evolving. In this review, we highlight recent progress in the field and offer readers a glimpse of the future for this bright and promising modality. Methods We compiled a narrative review of VNS literature using PubMed and organized the discussion by disease states with approved indications (epilepsy, depression, obesity, post-stroke motor rehabilitation, headache), followed by a section highlighting novel, exploratory areas of VNS research. In each section, we summarized the current role, recent advancements, and future directions of VNS in the treatment of each disease. Results The field continues to gain appreciation for the clinical potential of this modality. VNS was initially developed for treatment-resistant epilepsy, with the first depression studies following shortly thereafter. Overall, VNS has gained approval or clearance in the treatment of medication-refractory epilepsy, treatment-resistant depression, obesity, migraine/cluster headache, and post-stroke motor rehabilitation. Conclusion Noninvasive VNS represents an opportunity to bridge the translational gap between preclinical and clinical paradigms and may offer the same therapeutic potential as invasive VNS. Further investigation into how VNS parameters modulate behavior and biology, as well as how to translate noninvasive options into the clinical arena, are crucial next steps for researchers and clinicians studying VNS.

neurosciences,clinical neurology
Non-invasive Vagus Nerve Stimulation in Cerebral Stroke: Current Status and Future Perspectives

Lijuan Li,Dong Wang,Hongxia Pan,Liyi Huang,Xin Sun,Chengqi He,Quan Wei

DOI: https://doi.org/10.3389/fnins.2022.820665

IF: 4.3

2022-02-16

Frontiers in Neuroscience

Abstract:Stroke poses a serious threat to human health and burdens both society and the healthcare system. Standard rehabilitative therapies may not be effective in improving functions after stroke, so alternative strategies are needed. The FDA has approved vagus nerve stimulation (VNS) for the treatment of epilepsy, migraines, and depression. Recent studies have demonstrated that VNS can facilitate the benefits of rehabilitation interventions. VNS coupled with upper limb rehabilitation enhances the recovery of upper limb function in patients with chronic stroke. However, its invasive nature limits its clinical application. Researchers have developed a non-invasive method to stimulate the vagus nerve (non-invasive vagus nerve stimulation, nVNS). It has been suggested that nVNS coupled with rehabilitation could be a promising alternative for improving muscle function in chronic stroke patients. In this article, we review the current researches in preclinical and clinical studies as well as the potential applications of nVNS in stroke. We summarize the parameters, advantages, potential mechanisms, and adverse effects of current nVNS applications, as well as the future challenges and directions for nVNS in cerebral stroke treatment. These studies indicate that nVNS has promising efficacy in reducing stroke volume and attenuating neurological deficits in ischemic stroke models. While more basic and clinical research is required to fully understand its mechanisms of efficacy, especially Phase III trials with a large number of patients, these data suggest that nVNS can be applied easily not only as a possible secondary prophylactic treatment in chronic cerebral stroke, but also as a promising adjunctive treatment in acute cerebral stroke in the near future.

neurosciences
Vagus Nerve Stimulation in Ischemic Stroke

Sasan Andalib,Afshin A. Divani,Cenk Ayata,Sheharyar Baig,Ethem Murat Arsava,Mehmet Akif Topcuoglu,Eder Leonardo Cáceres,Vinay Parikh,Masoom J. Desai,Arshad Majid,Sara Girolami,Mario Di Napoli

DOI: https://doi.org/10.1007/s11910-023-01323-w

2023-11-28

Current Neurology and Neuroscience Reports

Abstract:Vagus nerve stimulation (VNS) has emerged as a potential therapeutic approach for neurological and psychiatric disorders. In recent years, there has been increasing interest in VNS for treating ischemic stroke. This review discusses the evidence supporting VNS as a treatment option for ischemic stroke and elucidates its underlying mechanisms.

neurosciences,clinical neurology
Vagus nerve stimulation: state of the art of stimulation and recording strategies to address autonomic function neuromodulation

David Guiraud,David Andreu,Stéphane Bonnet,Guy Carrault,Pascal Couderc,Albert Hagège,Christine Henry,Alfredo Hernandez,Nicole Karam,Virginie Le Rolle,Philippe Mabo,Paweł Maciejasz,Charles-Henri Malbert,Eloi Marijon,Sandrine Maubert,Chloé Picq,Olivier Rossel,Jean-Luc Bonnet

DOI: https://doi.org/10.1088/1741-2560/13/4/041002

IF: 5.043

2016-06-28

Journal of Neural Engineering

Abstract:OBJECTIVE: Neural signals along the vagus nerve (VN) drive many somatic and autonomic functions. The clinical interest of VN stimulation (VNS) is thus potentially huge and has already been demonstrated in epilepsy. However, side effects are often elicited, in addition to the targeted neuromodulation.APPROACH: This review examines the state of the art of VNS applied to two emerging modulations of autonomic function: heart failure and obesity, especially morbid obesity.MAIN RESULTS: We report that VNS may benefit from improved stimulation delivery using very advanced technologies. However, most of the results from fundamental animal studies still need to be demonstrated in humans.

engineering, biomedical,neurosciences
Vagus nerve stimulation for stroke rehabilitation: Neural substrates, neuromodulatory effects and therapeutic implications

Heidi M Schambra,Seth A Hays

DOI: https://doi.org/10.1113/JP285566

2024-09-07

Abstract:Paired vagus nerve stimulation (VNS) has emerged as a promising strategy to potentiate recovery after neurological injury. This approach, which combines short bursts of electrical stimulation of the vagus nerve with rehabilitation exercises, received approval from the US Food and Drug Aministration in 2021 as the first neuromodulation-based therapy for chronic stroke. Because this treatment is increasingly implemented in clinical practice, there is a need to take stock of what we know about this approach and what we have yet to learn. Here, we provide a survey on the foundational basis of VNS therapy for stroke and offer insight into the mechanisms that underlie potentiated recovery, focusing on the principles of neuromodulatory reinforcement. We discuss the current state of observations regarding synaptic reorganization in motor networks that are enhanced by VNS, and we propose other prospective loci of neuromodulation that should be evaluated in the future. Finally, we highlight the future opportunities and challenges to be faced as this approach is increasingly translated to clinical use. Collectively, a clearer understanding of the mechanistic basis of VNS therapy may reveal ways to maximize its benefits.
Molecular imaging of cardiac stem cell transplantation

Ahmad Y. Sheikh,Joseph C. Wu

DOI: https://doi.org/10.1007/S11886-006-0026-X

IF: 3.955

2006-03-01

Current Cardiology Reports

Abstract:
Vagus Nerve Stimulation in Ischemic Stroke: Old Wine in a New Bottle

Peter Y. Cai,Aakash Bodhit,Roselle Derequito,Saeed Ansari,Fawzi Abukhalil,Spandana Thenkabail,Sarah Ganji,Pradeepan Saravanapavan,Chandana C. Shekar,Sharatchandra Bidari,Michael F. Waters,Vishnumurthy Shushrutha Hedna

DOI: https://doi.org/10.3389/fneur.2014.00107

IF: 3.4

2014-06-24

Frontiers in Neurology

Abstract:Vagus nerve stimulation (VNS) is currently Food and Drug Administration-approved for treatment of both medically refractory partial-onset seizures and severe, recurrent refractory depression, which has failed to respond to medical interventions. Because of its ability to regulate mechanisms well-studied in neuroscience, such as norepinephrine and serotonin release, the vagus nerve may play an important role in regulating cerebral blood flow, edema, inflammation, glutamate excitotoxicity, and neurotrophic processes. There is strong evidence that these same processes are important in stroke pathophysiology. We reviewed the literature for the role of VNS in improving ischemic stroke outcomes by performing a systematic search for publications in Medline (1966-2014) with keywords "VNS AND stroke" in subject headings and key words with no language restrictions. Of the 73 publications retrieved, we identified 7 studies from 3 different research groups that met our final inclusion criteria of research studies addressing the role of VNS in ischemic stroke. Results from these studies suggest that VNS has promising efficacy in reducing stroke volume and attenuating neurological deficits in ischemic stroke models. Given the lack of success in Phase III trials for stroke neuroprotection, it is important to develop new therapies targeting different neuroprotective pathways. Further studies of the possible role of VNS, through normally physiologically active mechanisms, in ischemic stroke therapeutics should be conducted in both animal models and clinical studies. In addition, recent advent of a non-invasive, transcutaneous VNS could provide the potential for easier clinical translation.

neurosciences,clinical neurology
Clinical perspectives on vagus nerve stimulation: present and future

Eibhlin Goggins,Shuhei Mitani,Shinji Tanaka

DOI: https://doi.org/10.1042/CS20210507

2022-05-11

Clinical Science

Abstract:The vagus nerve, the great wanderer, is involved in numerous processes throughout the body and vagus nerve stimulation (VNS) has the potential to modulate many of these functions. This wide-reaching capability has generated much interest across a range of disciplines resulting in several clinical trials and studies into the mechanistic basis of VNS. This review discusses current preclinical and clinical evidence supporting the efficacy of VNS in different diseases and highlights recent...

medicine, research & experimental
High specific torque motor for propulsion system of aircraft

D. Golovanov,M. Galea,C. Gerada

DOI: https://doi.org/10.1109/ESARS-ITEC.2016.7841405

2016-11-01

Abstract:This paper proposes an analytical model that considers the torque characteristics for high specific torque synchronous machine with outer rotor and a Halbach permanent magnet array. The distribution of the magnetic field in the air gap is obtained with a linear assumption by solving Neumann's problem. The analytical model presented in the paper allows preliminary estimation and fast optimization of the machine's geometry and can be used to develop a first cut design of the machine. The application of the analytical model proposed is demonstrated via the adaptation and modification of a traction machine designed for electrical taxiing to a machine for propulsion of electric aircraft.
A Review of Parameter Settings for Invasive and Non-invasive Vagus Nerve Stimulation (VNS) Applied in Neurological and Psychiatric Disorders

Sean L Thompson,Georgia H O'Leary,Christopher W Austelle,Elise Gruber,Alex T Kahn,Andrew J Manett,Baron Short,Bashar W Badran,Sean L. Thompson,Georgia H. O’Leary,Christopher W. Austelle,Alex T. Kahn,Andrew J. Manett,Bashar W. Badran

DOI: https://doi.org/10.3389/fnins.2021.709436

IF: 4.3

2021-07-13

Frontiers in Neuroscience

Abstract:Vagus nerve stimulation (VNS) is an established form of neuromodulation with a long history of promising applications. Earliest reports of VNS in the literature date to the late 1800’s in experiments conducted by Dr. James Corning. Over the past century, both invasive and non-invasive VNS have demonstrated promise in treating a variety of disorders, including epilepsy, depression, and post-stroke motor rehabilitation. As VNS continues to rapidly grow in popularity and application, the field generally lacks a consensus on optimum stimulation parameters. Stimulation parameters have a significant impact on the efficacy of neuromodulation, and here we will describe the longitudinal evolution of VNS parameters in the following categorical progression: (1) animal models, (2) epilepsy, (3) treatment resistant depression, (4) neuroplasticity and rehabilitation, and (5) transcutaneous auricular VNS (taVNS). We additionally offer a historical perspective of the various applications and summarize the range and most commonly used parameters in over 130 implanted and non-invasive VNS studies over five applications.

neurosciences
Neurorehabilitation with vagus nerve stimulation: a systematic review

Radha Korupolu,Alyssa Miller,Andrew Park,Nuray Yozbatiran

DOI: https://doi.org/10.3389/fneur.2024.1390217

IF: 3.4

2024-05-30

Frontiers in Neurology

Abstract:Objective: To systematically review vagus nerve stimulation (VNS) studies to present data on the safety and efficacy on motor recovery following stroke, traumatic brain injury (TBI), and spinal cord injury (SCI). Methods: Data sources: PubMed, EMBASE, SCOPUS, and Cochrane. Study selection: Clinical trials of VNS in animal models and humans with TBI and SCI were included to evaluate the effects of pairing VNS with rehabilitation therapy on motor recovery. Data extraction: Two reviewers independently assessed articles according to the evaluation criteria and extracted relevant data electronically. Data synthesis: Twenty-nine studies were included; 11 were animal models of stroke, TBI, and SCI, and eight involved humans with stroke. While there was heterogeneity in methods of delivering VNS with respect to rehabilitation therapy in animal studies and human non-invasive studies, a similar methodology was used in all human-invasive VNS studies. In animal studies, pairing VNS with rehabilitation therapy consistently improved motor outcomes compared to controls. Except for one study, all human invasive and non-invasive studies with controls demonstrated a trend toward improvement in motor outcomes compared to sham controls post-intervention. However, compared to non-invasive, invasive VNS, studies reported severe adverse events such as vocal cord palsy, dysphagia, surgical site infection, and hoarseness of voice, which were found to be related to surgery. Conclusion: Our review suggests that VNS (non-invasive or invasive) paired with rehabilitation can improve motor outcomes after stroke in humans. Hence, VNS human studies are needed in these populations (referring to SCI and TBI?) or just SCI. There are risks related to device implantation to deliver invasive VNS compared to non-invasive VNS. Future human comparison studies are required to study and quantify the efficacy vs. risks of paired VNS delivered via different methods with rehabilitation, which would allow patients to make an informed decision. Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=330653.

neurosciences,clinical neurology
Closed-Loop Vagus Nerve Stimulation for the Treatment of Cardiovascular Diseases: State of the Art and Future Directions

Matteo Maria Ottaviani,Fabio Vallone,Silvestro Micera,Fabio A. Recchia

DOI: https://doi.org/10.3389/fcvm.2022.866957

IF: 3.6

2022-04-07

Frontiers in Cardiovascular Medicine

Abstract:The autonomic nervous system exerts a fine beat-to-beat regulation of cardiovascular functions and is consequently involved in the onset and progression of many cardiovascular diseases (CVDs). Selective neuromodulation of the brain-heart axis with advanced neurotechnologies is an emerging approach to corroborate CVDs treatment when classical pharmacological agents show limited effectiveness. The vagus nerve is a major component of the cardiac neuroaxis, and vagus nerve stimulation (VNS) is a promising application to restore autonomic function under various pathological conditions. VNS has led to encouraging results in animal models of CVDs, but its translation to clinical practice has not been equally successful, calling for more investigation to optimize this technique. Herein we reviewed the state of the art of VNS for CVDs and discuss avenues for therapeutic optimization. Firstly, we provided a succinct description of cardiac vagal innervation anatomy and physiology and principles of VNS. Then, we examined the main clinical applications of VNS in CVDs and the related open challenges. Finally, we presented preclinical studies that aim at overcoming VNS limitations through optimization of anatomical targets, development of novel neural interface technologies, and design of efficient VNS closed-loop protocols.

cardiac & cardiovascular systems
Magensaft, Gastritis und Peptisches Geschwür

F. Büchner

DOI: https://doi.org/10.1007/BF01740700

Klinische Wochenschrift

Abstract:
Vagus nerve stimulation as immunomodulatory therapy for stroke: A comprehensive review

Matyas Jelinek,Jolana Lipkova,Kamil Duris

DOI: https://doi.org/10.1016/j.expneurol.2023.114628

Abstract:Stroke is a devastating cerebrovascular pathology with high morbidity and mortality. Inflammation plays a central role in the pathophysiology of stroke. Vagus nerve stimulation (VNS) is a promising immunomodulatory method that has shown positive effects in stroke treatment, including neuroprotection, anti-apoptosis, anti-inflammation, antioxidation, reduced infarct volume, improved neurological scores, and promotion of M2 microglial polarization. In this review, we summarize the current knowledge about the vagus nerve's immunomodulatory effects through the cholinergic anti-inflammatory pathway (CAP) and provide a comprehensive assessment of the available experimental literature focusing on the use of VNS in stroke treatment.
Vagus nerve stimulation in the non-human primate: implantation methodology, characterization of nerve anatomy, target engagement and experimental applications

Aaron J. Suminski,Abigail Z. Rajala,Rasmus M. Birn,Ellie M. Mueller,Margaret E. Malone,Jared P. Ness,Caitlyn Filla,Kevin Brunner,Alan B. McMillan,Samuel O. Poore,Justin C. Williams,Dhanabalan Murali,Andrea Brzeczkowski,Samuel A. Hurley,Aaron M. Dingle,Weifeng Zeng,Wendell B. Lake,Kip A. Ludwig,Luis C. Populin

DOI: https://doi.org/10.1186/s42234-023-00111-8

2023-04-30

Bioelectronic Medicine

Abstract:Vagus nerve stimulation (VNS) is a FDA approved therapy regularly used to treat a variety of neurological disorders that impact the central nervous system (CNS) including epilepsy and stroke. Putatively, the therapeutic efficacy of VNS results from its action on neuromodulatory centers via projections of the vagus nerve to the solitary tract nucleus. Currently, there is not an established large animal model that facilitates detailed mechanistic studies exploring how VNS impacts the function of the CNS, especially during complex behaviors requiring motor action and decision making.

Endotoxin temporarily impairs canine jejunal absorption of water, electrolytes, and glucose

Exploring the potential of vagus nerve stimulation in treating brain diseases: a review of immunologic benefits and neuroprotective efficacy

Crystal structure of methionine aminopeptidase from hyperthermophile, Pyrococcus furiosus.

Neuroimmunomodulation of vagus nerve stimulation and the therapeutic implications

Advances in VNS efficiency and mechanisms of action on cognitive functions

Research advances in the application of vagus nerve electrical stimulation in ischemic stroke

Vagus nerve stimulation (VNS): recent advances and future directions

Non-invasive Vagus Nerve Stimulation in Cerebral Stroke: Current Status and Future Perspectives

Vagus Nerve Stimulation in Ischemic Stroke

Vagus nerve stimulation: state of the art of stimulation and recording strategies to address autonomic function neuromodulation

Vagus nerve stimulation for stroke rehabilitation: Neural substrates, neuromodulatory effects and therapeutic implications

Molecular imaging of cardiac stem cell transplantation

Vagus Nerve Stimulation in Ischemic Stroke: Old Wine in a New Bottle

Clinical perspectives on vagus nerve stimulation: present and future

High specific torque motor for propulsion system of aircraft

A Review of Parameter Settings for Invasive and Non-invasive Vagus Nerve Stimulation (VNS) Applied in Neurological and Psychiatric Disorders

Neurorehabilitation with vagus nerve stimulation: a systematic review

Closed-Loop Vagus Nerve Stimulation for the Treatment of Cardiovascular Diseases: State of the Art and Future Directions

Magensaft, Gastritis und Peptisches Geschwür

Vagus nerve stimulation as immunomodulatory therapy for stroke: A comprehensive review

Vagus nerve stimulation in the non-human primate: implantation methodology, characterization of nerve anatomy, target engagement and experimental applications